Lancome USA’s Products Are Being Marketed Without Prior Approval From The FDA

The Food and Drug Administration (FDA) recently reviewed Lancome USA’s website and determined that certain products, including but not limited to; Genifique Youth Activating Concentrate, Genefique Eye Youth Activating Eye Concentrate, Genefique Cream Serum Youth Activating Cream Serum, Genifique Repair Youth Activating Night Cream, Absolue Precious Cells Advanced Regenerating and Reconstructing Cream SPF 15 Sunscreen, are being promoted for uses that cause these products to be considered “drugs” under section 201(g)(1)(C) of the Federal Food, Drug, and Cosmetic Act (the “Act”). The claims on Lancome’s website indicate that these products are intended to affect the structure or any fuction of the human body, rendering them drugs under the Act. According to the US Food and Drug Administration, the marketing of these products with these claims evidencing these intended uses violates the Act.  The FDA further stated that these products are not generally recognized among qualified experts as safe and effective and, therefore, the products are new drugs as defined under the Act.  According to the FDA, a new drug may not be legally marketed in the U.S. without prior approval from the FDA in the form of an approved New Drug Application (NDA).  The attorneys at Balkan & Patterson, LLP are experienced in class action litigation and will act to protect consumers against corporate wrongdoers. If you believe you have potential for a class action, please contact us immediately and we will review your case at no charge.

The law firm of Balkan & Patterson, LLP was founded in 2006 and is headquartered in Boca Raton, Florida, at 601 S. Federal Highway, Suite 302, with offices in Broward County. Mr. Balkan and Mr. Patterson can be contacted at (561) 750-9191. Additional information about Balkan & Patterson, LLP may be obtained from the firm’s website at

Comments are closed.